Cargando…

Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas

PURPOSE: MDM2 and CDK4 are frequently co-amplified in well-differentiated/dedifferentiated liposarcoma (WDLPS/DDLPS). We aimed to determine whether combined MDM2/CDK4 targeting is associated with higher antitumour activity than a single agent in preclinical models of DDLPS. EXPERIMENTAL DESIGN: DDLP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laroche-Clary, Audrey, Chaire, Vanessa, Algeo, Marie-Paule, Derieppe, Marie-Alix, Loarer, François L., Italiano, Antoine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477309/ https://www.ncbi.nlm.nih.gov/pubmed/28629371 http://dx.doi.org/10.1186/s13045-017-0482-3

Ejemplares similares

MDM2 antagonists synergize with PI3K/mTOR inhibition in well-differentiated/dedifferentiated liposarcomas
por: Laroche, Audrey, et al.
Publicado: (2017)

MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies
por: Roy, Shomereeta, et al.
Publicado: (2020)

Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
por: Laroche, Audrey, et al.
Publicado: (2017)

Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting
por: Dadone-Montaudié, Bérengère, et al.
Publicado: (2020)

ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy Independent of Alternative Lengthening Telomere (ALT) Status
por: Laroche-Clary, Audrey, et al.
Publicado: (2020)

Genome-wide CRISPR/Cas9 library screening identified ATM signaling network genes as critical drivers for resistance to ATR inhibition in soft-tissue sarcomas: synthetic lethality and therapeutic implications
por: Spalato-Ceruso, M, et al.
Publicado: (2023)

Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications
por: Fourneaux, Benjamin, et al.
Publicado: (2016)

Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
por: Traweek, Raymond S., et al.
Publicado: (2022)

Prognostic impact of circulating tumor cells in patients with soft‐tissue sarcomas: a prospective study
por: Blanchi, Julie, et al.
Publicado: (2023)

PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53
por: Grellety, Thomas, et al.
Publicado: (2015)

Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report
por: Grifasi, Carlo, et al.
Publicado: (2013)

Cracking the riddle of dedifferentiated liposarcoma: is EV-MDM2 a key?
por: Casadei, Lucia, et al.
Publicado: (2020)

LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications
por: Ben-Ami, Eytan, et al.
Publicado: (2020)

MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models
por: Patt, Andrew, et al.
Publicado: (2020)

Challenging dedifferentiated liposarcoma identified by MDM2-amplification, a report of two cases
por: Lokka, Suvi, et al.
Publicado: (2014)

Hypopharyngeal Dedifferentiated Liposarcoma in the MDM2 Era: A Case Report and Short Review
por: Wanes, Peter, et al.
Publicado: (2020)

Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous dedifferentiation
por: Nguyen, Vinh N., et al.
Publicado: (2015)

Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers
por: Cassinelli, Giuliana, et al.
Publicado: (2022)

Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH
por: Al-Maghraby, Hatem Q., et al.
Publicado: (2010)

Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology
por: Kim, Yu Jin, et al.
Publicado: (2019)

Rare Aggressive Behavior of MDM2-Amplified Retroperitoneal Dedifferentiated Liposarcoma, with Brain, Lung and Subcutaneous Metastases
por: Ben Salha, Imen, et al.
Publicado: (2016)

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma
por: Seligson, Nathan D., et al.
Publicado: (2019)

Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma
por: Przybyl, Joanna, et al.
Publicado: (2022)

Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition
por: Fourneaux, Benjamin, et al.
Publicado: (2019)

Expression of Concern to: Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition
por: Fourneaux, Benjamin, et al.
Publicado: (2019)

Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
por: Dorian Yarih, Garcia-Ortega, et al.
Publicado: (2021)

Dedifferentiated liposarcoma of the retroperitoneum with osteosarcomatous component
por: Sun, Wenbin, et al.
Publicado: (2012)

Dedifferentiated Paratesticular Liposarcoma with Osseous Metaplasia
por: Chondros, Kostas, et al.
Publicado: (2015)

Dedifferentiated liposarcoma of the adult male breast
por: Raj, Sean D., et al.
Publicado: (2015)

Scattered genomic amplification in dedifferentiated liposarcoma
por: Mandahl, Nils, et al.
Publicado: (2017)

Multifocal Dedifferentiated Liposarcoma of the Jejunal Mesentery
por: Khanduri, Archana, et al.
Publicado: (2021)

Giant Retroperitoneal Mucinous Tumor Supportively Diagnosed as a Dedifferentiated Liposarcoma by Fluorescence In Situ Hybridization of MDM2 Gene
por: Naiki, Taku, et al.
Publicado: (2011)

High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies
por: Toulmonde, Maud, et al.
Publicado: (2020)

An unusual case of primary colonic dedifferentiated liposarcoma()
por: Türkoğlu, Mehmet Akif, et al.
Publicado: (2013)

Dedifferentiated Liposarcoma Occurring in the Right Pulmonary Hilum
por: Koike, Hirofumi, et al.
Publicado: (2017)

A case of dedifferentiated liposarcoma of the heart and stomach
por: Hisata, Yoichi, et al.
Publicado: (2017)

Dedifferentiated liposarcoma of the gallbladder: first reported case
por: da Costa, Adriano Carneiro, et al.
Publicado: (2018)

Adipogenesis induces growth inhibition of dedifferentiated liposarcoma
por: Kim, Yu Jin, et al.
Publicado: (2019)

Dedifferentiated spermatic cord liposarcoma with macroscopic ossification
por: Ando, Takashi, et al.
Publicado: (2018)

Integrated exome and RNA sequencing of dedifferentiated liposarcoma
por: Hirata, Makoto, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4j4vp20aafe003khrjr7hkhcch